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Abstract
Objective: The findings from truly randomized community-based studies on Staphylococcus aureus nasal colonization are
scarce. Therefore we have examined point prevalence and risk factors of S. aureus nasal carriage in a non-hospitalized
population of Braunschweig, northern Germany.
Methods: A total of 2026 potential participants were randomly selected through the resident’s registration office and
invited by mail. They were requested to collect a nasal swab at home and return it by mail. S. aureus was identified by
culture and PCR. Logistic regression was used to determine risk factors of S. aureus carriage.
Results: Among the invitees, 405 individuals agreed to participate and 389 provided complete data which was included in
the analysis. The median age of the participants was 49 years (IQR: 39–61) and 61% were females. S. aureus was isolated in
85 (21.9%; 95% CI: 18.0–26.2%) of the samples, five of which were MRSA (1.29%; 95% CI: 0.55–2.98%). In multiple logistic
regression, male sex (OR = 3.50; 95% CI: 2.01–6.11) and presence of allergies (OR = 2.43; 95% CI: 1.39–4.24) were found to be
associated with S. aureus nasal carriage. Fifty five different spa types were found, that clustered into nine distinct groups.
MRSA belonged to the hospital-associated spa types t032 and t025 (corresponds to MLST CC 22), whereas MSSA spa types
varied and mostly belonged to spa-CC 012 (corresponds to MLST CC 30), and spa-CC 084 (corresponds to MLST CC 15).
Conclusion: This first point prevalence study of S. aureus in a non-hospitalized population of Germany revealed prevalence,
consistent with other European countries and supports previous findings on male sex and allergies as risk factors of S.
aureus carriage. The detection of hospital-associated MRSA spa types in the community indicates possible spread of these
strains from hospitals into the community.
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Introduction
The increased awareness of community-acquired methicillin-
resistant Staphylococcus aureus (MRSA) requires reliable data on
the prevalence of S. aureus carriage in the general (non-
hospitalized) population. Population based studies from North
America and Europe indicate a prevalence of S. aureus between
18% and 30% [1–6]. Data on prevalence in the general
population of Germany - a country with a comparatively
intermediate MRSA incidence in hospitals are limited. In addition,
data are mostly assessed for selected population groups and
epidemiological information associated with S. aureus carriage is
rare [7,8]. We therefore examined point prevalence and risk
factors of S. aureus nasal carriage in a random sample of the non-
hospitalized population of Braunschweig, Germany, and com-
pared the findings with other prevalence assessments of nasal S.
aureus carriage in the general population in Europe and other
parts of the world. A secondary objective was to evaluate
molecular epidemiological data and antimicrobial resistance
patterns of S. aureus strains in the general population.
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Methods
Study area, data and sample collection
This is a community based study in the general population of
Braunschweig, a city with 246, 742 inhabitants in the Lower
Saxony, Germany [9]. In Germany, the residents’ registration
office of the city is a local authority where all citizens of that
particular area are obliged to register their address. Approximately
2000 men and women, 20–69 years of age were randomly selected
through the resident’s registration office of Braunschweig and
invited to participate in the study by mail, without taking any
consideration of risk factors of infection or health care contact of
participants. The study was planned as a feasibility study of the
German National Cohort (GNC), therefore only adult individuals
20 to 69 years of age were recruited [10]. As aimed for GNC, the
proportion of younger participants (20–29 years, 30–39 years) was
10% and for older participants (40–49 years, 50–59 years and 60–
69 years) the proportion was 26.7% and equal sex distribution of
participants was retained for recruitment in this study [10]. Study
aims and objectives were explained using information flyers to the
invited participants. Information about the study was also made
available through a press release in the local newspapers and on
the website of the Helmholtz Centre for Infection Research,
Braunschweig. A total of 405 persons agreed to participate in the
study. Participants were asked to provide a self-administered nasal
swab each month over a period of six months. To estimate point
prevalence, this analysis is based on the data from one time point,
i.e. first nasal swab received from each participant. Details of the
recruitment methods, non-responder analysis, and the feasibility of
obtaining serial self-collected nasal swabs, are reported separately
[11]. At recruitment, the study participants were also requested to
complete a questionnaire containing information on basic
demographic characteristics such as age, sex, and potential risk
factors for methicillin-sensitive and methicillin-resistant S. aureus
(MSSA and MRSA). The questionnaire items covered skin
infection, outpatient clinic visits, hospital stay of at least one
night, surgery, antibiotics prescribed, or international travel
occurring in the last 12 months, as well as pet animal contact,
occupational animal contact, presence of allergies, and presence of
diabetes mellitus. In addition, detailed and illustrated instructions
on how to collect a nasal swab were provided.
Laboratory analysis
All swabs (Amies agar gel swabs 108C, Copan Diagnostics,
Brescia, Italy) were inoculated on blood agar and in parallel on
Table 1. Descriptive characteristics of the study participants of the general population of Braunschweig, Germany.
Variables Categories N (%)
Sex Female 237 (60.9)
Male 152 (39.1)
Median age in years (inter quartile range) 49 (39–61)
Age 20–30 years 53 (13.6)
31–40 years 51 (13.01)
41–50 years 98 (25.2)
51–60 years 89 (22.9)
61–70 years 98 (25.2)
Allergies No 182 (46.8)
Yes 176 (45.2)
Diabetes mellitus No 365 (93.8)
Yes 16 (4.1)
Skin infection in the last 12 months No 272 (69.9)
Yes 104 (26.7)
Outpatient clinic visits in the last 12 months No 110 (28.3)
Yes 276 (71.0)
Hospital stay in the last 12 months No 341 (87.7)
Yes 44 (11.3)
Surgery in the last 12 months No 339 (87.1)
Yes 49 (12.6)
Prescribed antibiotics in the last 12 months No 225 (57.8)
Yes 158 (40.6)
Pet animal contact No 185 (47.6)
Yes 201 (51.7)
Occupational animals contact No 377 (96.9)
Yes 7 (1.8)
International travel in the last 12 months No 162 (41.6)
Yes 224 (57.6)
N = 389 (100%): Missing are included therefore percentage do not always add up to 100 percent.
doi:10.1371/journal.pone.0107937.t001
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MRSA chrome agar plates (BD Diagnostics, Heidelberg, Ger-
many). The plates were incubated at 37uC (Heraeus, Wehrheim,
Germany). Cultures were not kept for more than 48 hours in the
incubator. The appearance and growth score on blood agar were
recorded. Colonies suspected to be S. aureus were characterized
further with the slide coagulase test. Human blood plasma
received from a local hospital and fibrinogen from human blood
plasma (Sigma Aldrich, Inc. USA), were used for coagulase testing.
DNA was extracted from colonies with DNeasy Blood and Tissue
kit (Qiagen, Hilden, Germany). All S. aureus were subjected to
PCR targeting the spa and mecA genes, using standard primers as
described elsewhere [12,13]. Amplification conditions consisted of
3 min at 94uC, followed by 30 cycles of 30 sec at 94uC, 30 sec at
55uC, and 30 sec at 72uC, with a final step of 4 min at 72uC. The
DNA fragments were separated by gel electrophoresis on a 1.5%
agarose gel (Invitrogen, Merekel, Belgium) stained with ethidium
bromide.
PCR products were purified with the QIAquick Nucleotide
Removal Kit (Qiagen, Hilden, Germany). Molecular typing was
performed by means of spa-typing which is based on polymor-
phisms in the X-region of the spa gene. PCR amplification and
sequencing of this region was performed as described previously
[12]. The software Ridom StaphType (Ridom GmbH, Münster,
Germany) was used for spa sequence analysis and attribution to
types [14]. Based Upon Repeat Pattern (BURP) algorithm was
used to define spa clonal complexes (spa-CCs) with Ridom Staph
Type software [15]. Sequences containing less than 5 repeats were
excluded from the analysis and spa types were clustered if the cost
was less than or equal to 4, in order to prevent the formation of too
large and non-specific spa clusters.
As spa types can unambiguously be mapped to the correspond-
ing clonal lineages defined by multi locus sequence typing (MLST)
to a large extent [12], we have also enlisted MLST based clonal
complexes (MLST CC) according to the Ridom database (www.
ridom.com).
The antibiotic susceptibility patterns of S. aureus isolates were
checked for penicillin (susceptible #0.03), erythromycin (suscep-
tible #0.25), ciprofloxacin (susceptible #0.5), tetracycline (suscep-
tible #1), moxifloxacin (susceptible #0.25), oxacilin (susceptible #
0.25), clindamycin (susceptible #0.25), gentamicin (susceptible #
0.5), linezolid (susceptible #2), daptomycin (susceptible #0.25),
vancomycin (susceptible #0.5), tigecycline (susceptible #0.12),
fosfomycin (susceptible #8), fusidic acid (susceptible #0.5),
rifampicin (susceptible #0.5) and trimethoprim/sulphamethoxa-
zole (susceptible #10). The antibiotic susceptibility patterns were
determined with the VITEK II system (AST-P611 card, bioMér-
ieux, SA, Craponne, France) according to the manufacturer’s
instructions.
Statistical analysis
In descriptive statistics, frequency and proportions were
calculated for categorical variables and median and interquartile
range (IQR) was reported for continuous variables. Possible
determinants for S. aureus (including both MRSA and MSSA)
nasal carriage were first checked through univariable logistic
regression analysis. We applied multiple logistic regression by
stepwise backward selection of variables with biological plausibility
and a significance level of ,0.10 for entry into the model. All
statistical tests were considered significant with a p-value ,0.05.
Data were analyzed with IBM SPSS Statistics for Windows version
19.
Ethics statement
The study was approved by the Ethics Committee of the State
Board of Physicians of the German Federal State of Lower Saxony
and the German Federal Commissioner for Data Protection and
Freedom of Information (Approval letter numbers: Bo/13/2010
and 3137/2011). Written informed consent was obtained from all
study participants.
Results
Characteristics of the sample
Among the 2026 invited persons, 405 (20%) agreed to
participate and 389 (96%) of those participants sent a nasal swab
along with the questionnaire during the period of July –
September 2012. The study population included 237 (60.9%)
female participants and the median age of the study population
was 49 years (IQR: 39–61 years, range: 20–70 years). In the total
of 389 participants, 276 (71.0%) visited outpatient clinics, 44
Table 2. Profile of MRSA-positive cases identified in a random sample of 389 participants from the general population of
Braunschweig, Germany.
Individual characteristics Case 1 Case 2 Case 3 Case 4 Case 5
Age 28 49 56 64 29
Sex male female female female male







Family member working in health care yes no no no yes
Family member working in child care no no yes no no
Outpatient clinic visits in the last 12 months yes yes yes yes yes
Hospital stay in the last 12 months no no yes, operated in gynecology no no
Prescribed antibiotics in the last 12 months yes yes yes yes no
Pet animal contact cat no no no dog
International travel in the last 12 months yes no yes no yes
S. aureus spa type t032 t032 t025 t032 t032, *t330
Abbreviations: URTI; Upper respiratory tract infections, LRTI; Lower respiratory tract infections, GIT; Gastrointestinal tract infections.
*t330 was an MSSA.
doi:10.1371/journal.pone.0107937.t002
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(11.3%) had been in the hospital and 158 (40.6%) were prescribed
antibiotics, all in the last 12 months (Table 1).
S. aureus nasal carriage prevalence and risk factors
S. aureus was detected in nasal swabs of 85 participants (21.9%;
95% confidence interval [CI]: 18.0–26.2%). MRSA was detected
in five participants (1.29%; 95% CI: 0.55–2.98%), three of whom
were female. The age of the five MRSA positive cases ranged from
28 to 64 years, and all five cases had a prior upper respiratory tract
infection plus at least one of the following medical conditions: skin
infection, gastrointestinal infection, herpes, allergies, or cardiovas-
cular disease. Four of them had been prescribed antibiotics in the
12 months prior to the survey (Table 2).
In univariable logistic regression analysis, associations were
observed between nasal S. aureus carriage and male sex (odds
ratio [OR] = 2.66, 95% CI: 1.63–4.34) and presence of allergies
(OR = 1.85, 95% CI: 1.10–3.09); no significant association was
observed between nasal S. aureus carriage and pet animal contact,
diagnosis of diabetes mellitus, occupational animal contact or
outpatient clinic visits, prescribed antibiotics and international
travel in the last 12 months (Table 3). In multiple logistic
regression analysis, nasal carriage of S. aureus was also
significantly associated with male sex (OR = 3.50, 95% CI: 2.01–
6.11) and presence of allergies (OR = 2.43, 95% CI: 1.39–4.24).
Spa typing and BURP analysis
Among the 85 isolates, fifty four different MSSA spa types were
found, that clustered into nine distinct groups and two different
MRSA spa types were clustered into one group (figure 1, table 4).
Among the MSSA isolates, one cluster had no founder and 12 spa
types (12/54, 22%) could not be clustered into a spa-CC and were
classified as singletons. Six isolates (6/80, 8%) were excluded from
the analysis as the X-region amplimer contained less than five
repeats. Most MSSA spa types belonged to spa-CC 012 (16/80,
20%) and spa-CC 084 (15/80, 19%). Four of the MRSA belonged
to spa type t032 and one to spa type t025 and had no founder
(corresponds to MLST CC 22). From one sample, two different
spa types, t032 (MRSA, spa-CC 005) and spa type t330 (MSSA,
spa-CC 330/706) were isolated. MSSA spa types varied widely, 7
(9%) belong to spa types t012 (spa-CC 012, corresponds to MLST
Table 3. Univariable and multiple logistic regression analyses of factors associated with nasal S. aureus carriage among study
participants of the general population of Braunschweig, Germany.
Variables Categories
Univariable logistic regression
OR (95% CI) p-value
Multiple logistic
regression OR (95% CI) p-value
Sex Female 1 1
Male 2.66 (1.63–4.34) ,0.001 3.50 (2.01–6.11) ,0.001
Age 61–70 years 1 1
20–30 years 2.14 (1.00–4.56) 0.049 2.52 (1.08–5.88) 0.085
31–40 years 0.77 (0.31–1.91) 0.578 0.63 (0.23–1.71)
41–50 years 1.28 (0.64–2.53) 0.487 1.24 (0.59–2.64)
51–60 years 0.98 (0.47–2.03) 0.960 1.03 (0.46–2.29)
Allergies No 1 1
Yes 1.85 (1.10–3.09) 0.002 2.43 (1.39–4.24) 0.002
Diabetes mellitus No 1
Yes 1.21 (0.38–3.84) 0.751
Skin infection in the last 12 months No 1
Yes 1.35 (0.79–2.29) 0.262
Outpatient clinic visits in the last
12 months
No 1
Yes 0.94 (0.56–1.60) 0.833
Hospital stay in the last 12 months No 1
Yes 0.52 (0.21–1.28) 0.157
Surgery in the last 12 months No 1
Yes 1.04 (0.51–2.13) 0.922
Prescribed antibiotics in the last
12 months
No 1
Yes 0.85 (0.51–1.39) 0.506
Pet animal contact No 1 0.423
Yes 0.82 (0.51–1.33)
Occupational animal contact No 1
Yes 1.44 (0.27–7.55) 0.667
International travel in the last 12 months No 1
Yes 1.43 (0.87–2.36) 0.159
Abbreviations: OR; odds ratio, CI; confidence interval.
doi:10.1371/journal.pone.0107937.t003
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CC 30), 7 (9%) to spa types t091 (spa-CC 084, corresponds to
MLST CC 15) and 5 (6%) were spa types t021 (spa-CC 012). One
MSSA also had a spa type t032. We observed three new spa type’s
t13383, t13449 and t13588. One isolate was not typable (NT).
Relatedness of the spa types belonging to the same clonal lineages
identified by BURP analysis is shown in figure 1.
Antimicrobial susceptibility testing
Table 5 provides antibiotic resistance patterns of the 85 S.
aureus strains isolated from 389 study participants. Only 35
(41.2%) were sensitive to all tested antibiotics. Among the 85
isolates, resistance to penicillin was most common 49 (57.7%), and
frequent resistance to fluoroquinolones 9 (10.6%) was also
observed. All MRSA were resistant to penicillin and fluoroquin-
olones and one MRSA was also resistant to erythromycin and
clindamycin.
Discussion
We determined the prevalence of MSSA and MRSA carriage in
a random population-based study in one city of northern
Germany. Every fifth participant in our study was colonized with
S. aureus. In Europe, only two studies from the UK were based on
random population-based samples, as is our study [4,16]. Gamblin
et al found 28% nasal S. aureus colonization in Southampton,
which is close to a previous estimate of 23% by Abudu et al in
Birmingham [4,16]. Gamblin et al used a method similar to the
one used in our study [4,16]. The participants were requested to
collect nasal swabs at home and return them by mail. However,
the selection of participants from a single urban NHS general
practice may have overestimated the prevalence in contrast to our
study where a random sample was taken from the entire
population of the city. We had a majority of female participants,
which might lead to an underestimation of the prevalence detected
Figure 1. BURP analysis of the S. aureus spa types isolated from nasal swabs of 389 participants of the general population of
Braunschweig, Germany. Each spa type identified is depicted with circles. Related spa types are connected with a black line; resultant clonal
complexes are written in bold. The predicted founder of each clonal complex is indicated in blue and sub-founders are labelled in yellow. The size of
the circle is proportional to the frequency of the spa type in the population. Each clonal complex (CC) is defined by the predicted founder spa type or
by the spa types it contains.
doi:10.1371/journal.pone.0107937.g001
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in our study. In Italy and Norway, the prevalence of S. aureus is
reported to be 25.9% and 27% respectively in the general
community [3,17]. In Italy, the study included those people who
had visited university hospital for a voluntary check-up and in
Norway nasal S. aureus carriage was checked in visitors of the two
largest shopping centres in the region [3,17]. The sampling
approach in the Italian and Norwegian studies likely included an
even stronger probability for recruiting bias, which might partly
account for the higher S. aureus prevalence as compared to our
study [3,17]. In the US, only the studies by Gorwitz and Mainous
were truly based on a random population based samples, as was
the case in our study but resulted in higher S. aureus prevalence
estimates [2,18].
For the following reasons, we believe S. aureus prevalence
assessed in this study to be an underestimate of the true population
prevalence rather than an over estimate: (1) our study does not
include high risk age groups such as children or people over 69
years of age (2) swabs from body sites other than anterior nares,
Table 4. Distribution of spa-clonal complexes (spa-CCs) among isolates collected from nasal swabs of 389 participants of the




(% of all strains)
Number of spa-types
(% of all spa-types) MLST CC (ST)
spa-CC 084 t084, t091, t254, t360, t368, t491, t499, t4508 15 (19) 8 (15) CC 15
spa-CC 015 t015, t073, t550, t772, t2277, t13383 7 (9) 6 (11) CC 45
spa-CC 005 t005, t032, t1433, t1862 5 (6) 4 (7) CC 22
spa-CC 012 t012, t018, t019, t021, t275 16 (20) 5 (9) CC 30
spa-CC 706/330 t330, t706, t2275, t6311 4 (5) 4 (7)
spa-CC 002 t002, t242, t1265 4 (5) 3 (6) CC 5
spa-CC 304 t304, t2032, t11363 4 (5) 3 (6) CC 8
spa-CC 056 t056, t7760, t13588 3 (4) 3 (6) ST 101
No founder t078, t1925 2 (3) 2 (4) CC 45
Singletons t159, t160, t537, t1057, t1541, t2313,
t3741, t5337, t7088, t10983, t13449, t13587
14 (18) 12 (22)




(% of all strains)
Number of spa-types
(% of all spa-types) MLST CC (ST)
No founder t025, t032 5 (100) 2 (100) CC 22
Total samples n = 85 (100%), MSSA (n = 80): 9 groups, 12 singletons, 4 spa-types excluded,
MRSA (n = 5): 1 group.
doi:10.1371/journal.pone.0107937.t004
Table 5. Antimicrobial resistance patterns of S. aureus isolated from the nasal swabs of the 389 participants of the general
population of Braunschweig, Germany.
Antibiotic resistance Frequency Percent
Sensitive 35 41.2
PEN 38 44.7
PEN, CIP, MFL 2 2.4
PEN, CIP, MFL, ERY, CLI 1 1.2
PEN, ERY 1 1.2
PEN, ERY, CLI 1 1.2
PEN, OXA, CIP, MFL 4 4.7
PEN, OXA, CIP, MFL, ERY, CLI 1 1.2
PEN, TET 1 1.2
CIP, MFL 1 1.2
Total 85 100.0
Abbreviations: PEN: Penicillin, ERY: Erythromycin, CIP: Ciprofloxacin, TET: Tetracycline, MFL: Moxifloxacin, OXA: Oxacilin, CLI: Clindamycin.
All isolates tested were susceptible to vancomycin, tigecycline, gentamicin, linezolid, daptomycin, fosfomycin, fusidic acid, rifampicin and trimethoprim/
sulphamethoxazole.
doi:10.1371/journal.pone.0107937.t005
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such as pharyngeal and skin swabs, were not taken, (3) enrichment
culture techniques were not used to enhance S. aureus detection.
We observed 1.3% MRSA prevalence in the community. This
MRSA prevalence is lower than the previous estimate of MRSA
colonization observed in one of the studies at the time of hospital
admission in the state of Saarland, Germany [19] but quite similar
to the estimates in the UK (1.1%), France (1.02%) and Italy
(0.12%) taking the reported confidence intervals into account
[3,4,20]. MRSA prevalence assessed in this study is not much
different from other European studies and is slightly lower
compared to the US (2.1%) as reported in one of the studies
conducted on a large population-based random sample of 4666
adult participants [18]. MRSA prevalence appears to be
significantly lower in Europe as compared to other parts of the
world such as India (5.3%), China (3.6%) and Pakistan (2.8%) [21–
23]. However, a high MRSA prevalence in these studies may be
due to selection bias in the study design or less stringent
antimicrobial treatment regimens and hygiene measures up to
some extent.
Our finding that males were more likely to carry S. aureus is
consistent with other studies [17,18,24,25]. One of the recent
population based studies conducted in Denmark on middle-aged
and elderly twins also reported that men had a higher risk of S.
aureus nasal carriage [24], indicating gender specific risk factors,
not yet well understood, but also in line with observations from
Norway, Denmark, Australia, New Zealand and the USA
[17,18,24–28]. In contrast, more female carriers were observed
in the National Health and Nutrition Examination Survey (2001)
in the USA [2,29]. Interestingly, a recent study in the South West
of Germany found a significantly higher proportion of S. aureus
colonization among females taking hormonal contraceptives [8];
this finding revives the discussion on hormonal disposition to S.
aureus carriage. The literature is inconclusive with respect to
differences in age [18,24,26]. Some studies found a higher
prevalence in elderly people while others found a higher
prevalence in younger adults.
Our findings confirm previously reported associations between
allergies and S. aureus carriage [24,25]. S. aureus toxins have
been shown to accelerate allergic reactions in atopic diseases,
asthma and allergic rhinitis, but a satisfactory mechanistic
explanation for this observation has, so far, not been provided
[24,28,30–31]. The other known risk factors could not be
confirmed with significant associations in our study. Although
the respective trends were visible, our study population most likely
had insufficient power regarding less prevalent risk factors in the
general population.
MRSA spa types t032 and t025 (MLST CC 22) represent the
most frequent epidemic MRSA in German hospitals and are
disseminated worldwide [32,33,34]. Spread of MRSA CC22 to the
community was recently reported from countries with high
prevalence of MRSA in hospitals [35,36]. The high prevalence
of particular clonal complexes observed in this study such as CC
15, CC30, and CC45 was also reported for isolates from nasal
carriage by the study of Holtfreter et al., performed in Germany in
2006 and also for isolates from the Netherlands, the USA and
Portugal [7,37,38,39]. These clonal complexes obviously have
evolved as very successful colonizers of humans. The reasons for
this success remain unknown so far. As nasal colonization is a main
reservoir from which infections can start, it is no surprise to see
isolates attributed to CC15 and to CC30 among the most frequent
ones in a European study on S. aureus from invasive infections
[40]. The multiple strain carriage was rare as only person was
carrying MRSA spa type t032 and MSSA spa type t330.
More than half (60%) of the strains were resistant to one or
more antibiotics and resistance to penicillin was most common.
The MRSA isolates were also resistant to multiple antibiotics.
Among MSSA isolates, the prevalence of resistance to fluoroquin-
olones, macrolides, aminoglycosides and other antibiotic classes
(except penicillin) was still very low.
One of the limitations of this study is the possibility of selection
bias. Although selection of the potential participant through the
resident’s registration office was random, response and participa-
tion in the study can be affected by age, sex and health related
factors within the individuals. We had significantly more female
participants (61%) as compared to the general population in
Braunschweig (51%) [41]. Our response proportion of 20% is
comparable with other studies based on invitation to participants
through mail [4,42]. However, the response proportion of the
invitation accepting participants to send a nasal swab and the
questionnaire was over 90%, which is also comparable with other
studies [4,42]. Use of self-swabbing may affect the quality of swab
sampling. Sampling suitability was checked by the presence of
microorganisms in general and only 3 (0.8%) had no bacterial
growth [11]. Perfect agreement in terms of viral pathogen
detection by PCR was observed in a previous study comparing
staff-collected and participant-collected nasal swabs [43].
Conclusion
This is the first study of S. aureus and MRSA point prevalence
based on a random sample in a non-hospitalized population in
Germany. It shows that S. aureus colonization in the Braunsch-
weig population is similar to the reports available from other
European countries. MRSA carriage is relatively uncommon in
this community. The detection of hospital-associated MRSA spa
types in the community indicate possible spread of these strains
from hospitals into the community. Given the positive experience
with self-sampling in a general population based design, a larger
point prevalence study, including children and elderly people
might help to establish risk factors for MRSA in the general
population, which would in turn contribute relevant evidence for
screening algorithms and other prevention methods.
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